<< Arsenic-based additive used in chicken feed may pose health risks to humans | A woman's chance of undergoing a hysterectomy can now be accurately predicted >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Atrium Medical receives FDA approval for Omega 3 surgical mesh product

Published on April 10, 2007 at 5:52 AM · No Comments

Atrium Medical Corporation has announced it has obtained US FDA 510(K) approval for a new Omega 3 surgical mesh product called C-QURLite Mesh.

This new product is indicated for use in the surgical repair and reinforcement of soft tissue, including hernia repair -- a common procedure performed more than 700,000 times in the US each year. This novel technology combines Atrium's ProLite Ultra(TM) polypropylene surgical mesh with a proprietary, pharmaceutical grade Omega 3 fatty acid bio-absorbable gel coating. Unlike traditional tissue separating mesh products, C-QURLite Mesh enhances the handling stiffness and healing response in pre-peritoneal placement when compared to other "bare" polymer mesh products currently used for hernia repair.

C-QURLite Mesh is constructed from the refined ProLite Ultra polypropylene monofilament, providing a low profile, strong, lightweight base structure. The novel all natural Omega 3 gel coating is then applied in a proprietary method, coating each monofilament of the mesh to enhance material handling and subsequent healing. This non-polymeric, bio-absorbable coating has demonstrated in pre-clinical studies to significantly improve anatomical conformance by reducing aggressive, dense acellular collagen formation known to induce adhesions following surgery.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading